Biblio

Author Title [ Type

] Year

Filters: Author is Maury, Sébastien [Clear All Filters]

Journal Article

Redjoul R, Beckerich F, De Luna G, Leclerc M, Hebert N, Sloma I, Menouche D, Bartolucci P, Maury S. ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: a case-story with two successive HLA-matched sibling donors. Am J Hematol. 2022.

Leclerc M, Fourati S, Menouche D, Challine D, Maury S. Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors. Lancet Haematol. 2021.

Lacan C, Lambert J, Forcade E, Robin M, Chevallier P, Loron S, Bulabois C-E, Orvain C, Ceballos P, Daguindau E, et al. Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry. J Hematol Oncol. 2024;17(1):2.

Delbos F, Barhoumi W, Cabanne L, Beckerich F, Robin C, Redjoul R, Astati S, Toma A, Pautas C, Ansart-Pirenne H, et al. Donor immunization against human leukocyte class II antigens is a risk factor for graft-versus-host disease. Biol Blood Marrow Transplant. 2015.

Caillot L, Leclerc M, Sleiman EJacques Ra, Sloma I, Wagner-Ballon O, Claudel A, Beckerich F, Redjoul R, Robin C, Parinet V, et al. Long-term outcome after autologous BCR::ABL1-negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study. Haematologica. 2023.

Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, de la Tour RPeffault, Bretagne S, Bastuji-Garin S. Mainly post-transplant factors are associated with invasive aspergillosis after allogeneic stem cell transplantation. A study from the SAIF and SFGM-TC. Biol Blood Marrow Transplant. 2018.

Michel C, Robin M, Morisset S, Blaise D, Maertens J, Chevalier P, Castilla-Llorente C, Forcade E, Ceballos P, Yakoug-Agha I, et al. Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplant. 2023.

Fenwarth L, Thomas X, de Botton S, Duployez N, Bourhis J-H, Lesieur A, Fortin G, Meslin P-A, Yakoub-Agha I, Sujobert P, et al. A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia. Blood. 2020.

Dhedin N, Huynh A, Maury S, Tabrizi R, Beldjord K, Asnafi V, Thomas X, Chevallier P, Nguyen S, Coiteux V, et al. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood. 2015.

Thiolat A, Pilon C, Caudana P, Moatti A, To NHanh, Sedlik C, Leclerc M, Maury S, Piaggio E, Cohen JL. Treg-targeted IL-2/anti-IL-2 complex controls graft--host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation. Haematologica. 2023.